ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global and India Peptide CDMO Market Report & Forecast 2023-2029
Published Date: December 2023
|
Report Code: QYRE-Auto-23O15820
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global and India Peptide CDMO Market Report Forecast 2023 2029
BUY CHAPTERS

Global and India Peptide CDMO Market Report & Forecast 2023-2029

Code: QYRE-Auto-23O15820
Report
December 2023
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Company
Group
Bachem
PolyPeptide
CordenPharma
AmbioPharm
USV Peptides
Thermofischer
Bio Basic
JPT
GenScript
Xinbang Pharma
ScinoPharm
SN Biopharm
CBL
Piramal Pharma
CPC Scientific

and India Peptide CDMO Market Size

The global Peptide CDMO revenue was US$ 3173.9 million in 2022 and is forecast to a readjusted size of US$ 8611.6 million by 2029 with a CAGR of 15.0% during the review period (2023-2029).

and India Peptide CDMO Market

and India Peptide CDMO Market

Peptides are synthesized by coupling the carboxyl group of one amino acid to the amino group of another amino acid molecule. Due to the possibility of unintended reactions, protecting groups are common necessary. Chemical peptide synthesis most commonly starts at the carboxyl end of the peptide, and thus progress toward the amino-terminus. This is the opposite direction of protein biosynthesis.
A contract development and manufacturing company (CDMO) is a company within the pharmaceutical industry that provides drug development and manufacturing services. Pharmaceutical companies partner with CDMOs as a way to outsource drug development and drug manufacturing.
CDMO peptides production via contract peptide manufacturing is to optimize process development and achieve highly efficient conversion at every amino acid coupling to produce a high-purity crude synthetic custom peptide and minimize the demands on downstream processing.
In India, the Peptide CDMO revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period 2023-2029.
Global key peptide CDMO producers include Bachem, PolyPeptide, CordenPharma, and others. The top five manufacturers together account for 40% of the market share, with the largest manufacturer being Bachem with 17%. At the sales level, North America is the largest sales market with a market share of over 50%, followed by Europe and China with 33% and 9% respectively. In terms of product categories, it is divided into APIs and intermediates and FDF, with the former holding the major market share of 67%. In terms of application, commercial is the top application area with a market share of 76%, followed by academic research institutions.
This report focuses on global and India Peptide CDMO market, also covers the segmentation data of other regions in regional level and county level.
India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.
India is a market full of opportunities, and the demand for Peptide CDMO will continue to grow rapidly in the future.
Global Peptide CDMO Scope and Market Size
Peptide CDMO market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Peptide CDMO market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2029.
For India market, this report focuses on the Peptide CDMO market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Peptide CDMO Market Report

Report Metric Details
Report Name and India Peptide CDMO Market
Forecasted market size in 2029 US$ 8611.6 million
CAGR 15.0%
Forecasted years 2023 - 2029
Segment by Type
Segment by Application
  • Commercial
  • Academic Research
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bachem, PolyPeptide, CordenPharma, AmbioPharm, USV Peptides, Thermofischer, Bio Basic, JPT, Genscript, Xinbang Pharma, ScinoPharm, SN Biopharm, CBL, Piramal Pharma, CPC Scientific
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Peptide CDMO Market size in 2029?

Ans: The and India Peptide CDMO Market size in 2029 will be US$ 8611.6 million.

What is the market share of major companies in and India Peptide CDMO Market?

Ans: The top five manufacturers together account for 40% of the market share, with the largest manufacturer being Bachem with 17%.

What is the and India Peptide CDMO Market share by region?

Ans: According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

Who are the main players in the and India Peptide CDMO Market report?

Ans: The main players in the and India Peptide CDMO Market are Bachem, PolyPeptide, CordenPharma, AmbioPharm, USV Peptides, Thermofischer, Bio Basic, JPT, Genscript, Xinbang Pharma, ScinoPharm, SN Biopharm, CBL, Piramal Pharma, CPC Scientific

What are the Application segmentation covered in the and India Peptide CDMO Market report?

Ans: The Applications covered in the and India Peptide CDMO Market report are Commercial, Academic Research, Other

What are the Type segmentation covered in the and India Peptide CDMO Market report?

Ans: The Types covered in the and India Peptide CDMO Market report are APIs and Intermediates, FDF

Recommended Reports

CDMO Market Landscape

Therapeutic CDMO Segments

Small and Large Molecules

1 Study Coverage
1.1 Peptide CDMO Product Introduction
1.2 Global Peptide CDMO Outlook 2018 VS 2022 VS 2029
1.2.1 Global Peptide CDMO Market Size for the Year 2018-2029
1.2.2 India Peptide CDMO Market Size for the Year 2018-2029
1.3 Peptide CDMO Market Size, India VS Global, 2018 VS 2022 VS 2029
1.3.1 The Market Share of India Peptide CDMO in Global, 2018 VS 2022 VS 2029
1.3.2 The Growth Rate of Peptide CDMO Market Size, India VS Global, 2018 VS 2022 VS 2029
1.4 Peptide CDMO Market Dynamics
1.4.1 Peptide CDMO Industry Trends
1.4.2 Peptide CDMO Market Drivers
1.4.3 Peptide CDMO Market Challenges
1.4.4 Peptide CDMO Market Restraints
1.5 Assumptions and Limitations
1.6 Study Objectives
1.7 Years Considered
2 Peptide CDMO by Type
2.1 Peptide CDMO Market Segment by Type
2.1.1 APIs and Intermediates
2.1.2 FDF
2.2 Global Peptide CDMO Market Size by Type (2018, 2022 & 2029)
2.3 Global Peptide CDMO Market Size by Type (2018-2029)
2.4 India Peptide CDMO Market Size by Type (2018, 2022 & 2029)
2.5 India Peptide CDMO Market Size by Type (2018-2029)
3 Peptide CDMO by Application
3.1 Peptide CDMO Market Segment by Application
3.1.1 Commercial
3.1.2 Academic Research
3.1.3 Other
3.2 Global Peptide CDMO Market Size by Application (2018, 2022 & 2029)
3.3 Global Peptide CDMO Market Size by Application (2018-2029)
3.4 India Peptide CDMO Market Size by Application (2018, 2022 & 2029)
3.5 India Peptide CDMO Market Size by Application (2018-2029)
4 Global Peptide CDMO Competitor Landscape by Company
4.1 Global Peptide CDMO Market Size by Company
4.1.1 Global Key Companies of Peptide CDMO, Ranked by Revenue (2022)
4.1.2 Global Peptide CDMO Revenue by Player (2018-2023)
4.2 Global Peptide CDMO Concentration Ratio (CR)
4.2.1 Peptide CDMO Market Concentration Ratio (CR) (2018-2023)
4.2.2 Global Top 5 and Top 10 Largest Companies of Peptide CDMO in 2022
4.2.3 Global Peptide CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Players of Peptide CDMO Head office and Area Served
4.4 Global Key Players of Peptide CDMO, Product and Application
4.5 Global Key Players of Peptide CDMO, Date of Enter into This Industry
4.6 Companies Mergers & Acquisitions, Expansion Plans
4.7 India Peptide CDMO Market Size by Company
4.7.1 Key Players of Peptide CDMO in India, Ranked by Revenue (2022)
4.7.2 India Peptide CDMO Revenue by Players (2021, 2022 & 2023)
5 Global Peptide CDMO Market Size by Region
5.1 Global Peptide CDMO Market Size by Region: 2018 VS 2022 VS 2029
5.2 Global Peptide CDMO Market Size by Region (2018-2029)
5.2.1 Global Peptide CDMO Market Size by Region: 2018-2023
5.2.2 Global Peptide CDMO Market Size by Region (2024-2029)
6 Americas
6.1 Americas Peptide CDMO Market Size YoY Growth 2018-2029
6.2 Americas Peptide CDMO Market Size by Type
6.2.1 Americas Peptide CDMO Market Size by Type (2018-2023)
6.2.2 Americas Peptide CDMO Market Size by Type (2024-2029)
6.2.3 Americas Peptide CDMO Market Share by Type (2018-2029)
6.3 Americas Peptide CDMO Market Size by Application
6.3.1 Americas Peptide CDMO Market Size by Application (2018-2023)
6.3.2 Americas Peptide CDMO Market Size by Application (2024-2029)
6.3.3 Americas Peptide CDMO Market Share by Application (2018-2029)
6.4 Americas Peptide CDMO Market Facts & Figures by Country (2018, 2022 & 2029)
6.4.1 United States
6.4.2 Canada
6.4.3 Mexico
6.4.4 Brazil
7 EMEA
7.1 EMEA Peptide CDMO Market Size YoY Growth 2018-2029
7.2 EMEA Peptide CDMO Market Size by Type
7.2.1 EMEA Peptide CDMO Market Size by Type (2018-2023)
7.2.2 EMEA Peptide CDMO Market Size by Type (2024-2029)
7.2.3 EMEA Peptide CDMO Market Share by Type (2018-2029)
7.3 EMEA Peptide CDMO Market Size by Application
7.3.1 EMEA Peptide CDMO Market Size by Application (2018-2023)
7.3.2 EMEA Peptide CDMO Market Size by Application (2024-2029)
7.3.3 EMEA Peptide CDMO Market Share by Application (2018-2029)
7.4 EMEA Peptide CDMO Market Facts & Figures by Country (2018, 2022 & 2029)
7.4.1 Europe
7.4.2 Middle East
7.4.3 Africa
8 China
8.1 China Peptide CDMO Market Size YoY Growth 2018-2029
8.2 China Peptide CDMO Market Size by Type
8.2.1 China Peptide CDMO Market Size by Type (2018-2023)
8.2.2 China Peptide CDMO Market Size by Type (2024-2029)
8.2.3 China Peptide CDMO Market Share by Type (2018-2029)
8.3 China Peptide CDMO Market Size by Application
8.3.1 China Peptide CDMO Market Size by Application (2018-2023)
8.3.2 China Peptide CDMO Market Size by Application (2024-2029)
8.3.3 China Peptide CDMO Market Share by Application (2018-2029)
9 APAC (excluding China)
9.1 APAC Peptide CDMO Market Size YoY Growth 2018-2029
9.2 APAC Peptide CDMO Market Size by Type
9.2.1 APAC Peptide CDMO Market Size by Type (2018-2023)
9.2.2 APAC Peptide CDMO Market Size by Type (2024-2029)
9.2.3 APAC Peptide CDMO Market Share by Type (2018-2029)
9.3 APAC Peptide CDMO Market Size by Application
9.3.1 APAC Peptide CDMO Market Size by Application (2018-2023)
9.3.2 APAC Peptide CDMO Market Size by Application (2024-2029)
9.3.3 APAC Peptide CDMO Market Share by Application (2018-2029)
9.4 APAC Peptide CDMO Market Facts & Figures by Country (2018, 2022 & 2029)
9.4.1 Japan
9.4.2 South Korea
9.4.3 China Taiwan
9.4.4 Southeast Asia
9.4.5 India
10 Key Players Profiles
10.1 Bachem
10.1.1 Bachem Company Details
10.1.2 Bachem Business Overview
10.1.3 Bachem Peptide CDMO Introduction
10.1.4 Bachem Revenue in Peptide CDMO Business (2018-2023)
10.1.5 Bachem Recent Development
10.2 PolyPeptide
10.2.1 PolyPeptide Company Details
10.2.2 PolyPeptide Business Overview
10.2.3 PolyPeptide Peptide CDMO Introduction
10.2.4 PolyPeptide Revenue in Peptide CDMO Business (2018-2023)
10.2.5 PolyPeptide Recent Development
10.3 CordenPharma
10.3.1 CordenPharma Company Details
10.3.2 CordenPharma Business Overview
10.3.3 CordenPharma Peptide CDMO Introduction
10.3.4 CordenPharma Revenue in Peptide CDMO Business (2018-2023)
10.3.5 CordenPharma Recent Development
10.4 AmbioPharm
10.4.1 AmbioPharm Company Details
10.4.2 AmbioPharm Business Overview
10.4.3 AmbioPharm Peptide CDMO Introduction
10.4.4 AmbioPharm Revenue in Peptide CDMO Business (2018-2023)
10.4.5 AmbioPharm Recent Development
10.5 USV Peptides
10.5.1 USV Peptides Company Details
10.5.2 USV Peptides Business Overview
10.5.3 USV Peptides Peptide CDMO Introduction
10.5.4 USV Peptides Revenue in Peptide CDMO Business (2018-2023)
10.5.5 USV Peptides Recent Development
10.6 Thermofischer
10.6.1 Thermofischer Company Details
10.6.2 Thermofischer Business Overview
10.6.3 Thermofischer Peptide CDMO Introduction
10.6.4 Thermofischer Revenue in Peptide CDMO Business (2018-2023)
10.6.5 Thermofischer Recent Development
10.7 Bio Basic
10.7.1 Bio Basic Company Details
10.7.2 Bio Basic Business Overview
10.7.3 Bio Basic Peptide CDMO Introduction
10.7.4 Bio Basic Revenue in Peptide CDMO Business (2018-2023)
10.7.5 Bio Basic Recent Development
10.8 JPT
10.8.1 JPT Company Details
10.8.2 JPT Business Overview
10.8.3 JPT Peptide CDMO Introduction
10.8.4 JPT Revenue in Peptide CDMO Business (2018-2023)
10.8.5 JPT Recent Development
10.9 Genscript
10.9.1 Genscript Company Details
10.9.2 Genscript Business Overview
10.9.3 Genscript Peptide CDMO Introduction
10.9.4 Genscript Revenue in Peptide CDMO Business (2018-2023)
10.9.5 Genscript Recent Development
10.10 Xinbang Pharma
10.10.1 Xinbang Pharma Company Details
10.10.2 Xinbang Pharma Business Overview
10.10.3 Xinbang Pharma Peptide CDMO Introduction
10.10.4 Xinbang Pharma Revenue in Peptide CDMO Business (2018-2023)
10.10.5 Xinbang Pharma Recent Development
10.11 ScinoPharm
10.11.1 ScinoPharm Company Details
10.11.2 ScinoPharm Business Overview
10.11.3 ScinoPharm Peptide CDMO Introduction
10.11.4 ScinoPharm Revenue in Peptide CDMO Business (2018-2023)
10.11.5 ScinoPharm Recent Development
10.12 SN Biopharm
10.12.1 SN Biopharm Company Details
10.12.2 SN Biopharm Business Overview
10.12.3 SN Biopharm Peptide CDMO Introduction
10.12.4 SN Biopharm Revenue in Peptide CDMO Business (2018-2023)
10.12.5 SN Biopharm Recent Development
10.13 CBL
10.13.1 CBL Company Details
10.13.2 CBL Business Overview
10.13.3 CBL Peptide CDMO Introduction
10.13.4 CBL Revenue in Peptide CDMO Business (2018-2023)
10.13.5 CBL Recent Development
10.14 Piramal Pharma
10.14.1 Piramal Pharma Company Details
10.14.2 Piramal Pharma Business Overview
10.14.3 Piramal Pharma Peptide CDMO Introduction
10.14.4 Piramal Pharma Revenue in Peptide CDMO Business (2018-2023)
10.14.5 Piramal Pharma Recent Development
10.15 CPC Scientific
10.15.1 CPC Scientific Company Details
10.15.2 CPC Scientific Business Overview
10.15.3 CPC Scientific Peptide CDMO Introduction
10.15.4 CPC Scientific Revenue in Peptide CDMO Business (2018-2023)
10.15.5 CPC Scientific Recent Development
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.2 Data Source
12.2 Disclaimer
12.3 Author Details
FEATURED COMPANIES
Company
Group
Bachem
PolyPeptide
CordenPharma
AmbioPharm
USV Peptides
Thermofischer
Bio Basic
JPT
GenScript
Xinbang Pharma
ScinoPharm
SN Biopharm
CBL
Piramal Pharma
CPC Scientific
List of Tables
    Table 1. Peptide CDMO Market Size India VS Global, CAGR (2018 VS 2022 VS 2029)
    Table 2. Peptide CDMO Market Trends
    Table 3. Peptide CDMO Market Drivers
    Table 4. Peptide CDMO Market Challenges
    Table 5. Peptide CDMO Market Restraints
    Table 6. Global Peptide CDMO Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 7. India Peptide CDMO Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)
    Table 8. Global Peptide CDMO Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 9. India Peptide CDMO Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 10. Global Key Companies of Peptide CDMO, Ranked by Revenue (2022) & (US$ Million)
    Table 11. Global Peptide CDMO Revenue by Player, (US$ Million), 2018-2023
    Table 12. Global Peptide CDMO Revenue Share by Player, 2018-2023
    Table 13. Global Peptide CDMO Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Peptide CDMO by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide CDMO as of 2022)
    Table 15. Global Key Players of Peptide CDMO, Headquarters and Area Served
    Table 16. Global Key Players of Peptide CDMO, Product and Application
    Table 17. Global Key Players of Peptide CDMO, Date of Enter into This Industry
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Key Players of Peptide CDMO in India, Ranked by Revenue (2022) & (US$ Million)
    Table 20. India Peptide CDMO Revenue by Players, (US$ Million), 2021, 2022 & 2023
    Table 21. India Peptide CDMO Revenue Share by Players, 2021, 2022 & 2023
    Table 22. Global Peptide CDMO Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 23. Global Peptide CDMO Market Size by Region (2018-2023) & (US$ Million)
    Table 24. Global Peptide CDMO Market Size Forecast by Region (2024-2029) & (US$ Million)
    Table 25. Americas Peptide CDMO Market Size by Type (2018-2023) & (US$ Million)
    Table 26. Americas Peptide CDMO Market Size by Type (2024-2029) & (US$ Million)
    Table 27. Americas Peptide CDMO Market Size by Application (2018-2023) & (US$ Million)
    Table 28. Americas Peptide CDMO Market Size by Application (2024-2029) & (US$ Million)
    Table 29. Americas Peptide CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 30. Americas Peptide CDMO Market Size by Country (2018-2023) & (US$ Million)
    Table 31. Americas Peptide CDMO Market Size by Country (2024-2029) & (US$ Million)
    Table 32. EMEA Peptide CDMO Market Size by Type (2018-2023) & (US$ Million)
    Table 33. EMEA Peptide CDMO Market Size by Type (2024-2029) & (US$ Million)
    Table 34. EMEA Peptide CDMO Market Size by Application (2018-2023) & (US$ Million)
    Table 35. EMEA Peptide CDMO Market Size by Application (2024-2029) & (US$ Million)
    Table 36. EMEA Peptide CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 37. EMEA Peptide CDMO Market Size by Country (2018-2023) & (US$ Million)
    Table 38. EMEA Peptide CDMO Market Size by Country (2024-2029) & (US$ Million)
    Table 39. China Peptide CDMO Market Size by Type (2018-2023) & (US$ Million)
    Table 40. China Peptide CDMO Market Size by Type (2024-2029) & (US$ Million)
    Table 41. China Peptide CDMO Market Size by Application (2018-2023) & (US$ Million)
    Table 42. China Peptide CDMO Market Size by Application (2024-2029) & (US$ Million)
    Table 43. China Peptide CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 44. APAC Peptide CDMO Market Size by Type (2018-2023) & (US$ Million)
    Table 45. APAC Peptide CDMO Market Size by Type (2024-2029) & (US$ Million)
    Table 46. APAC Peptide CDMO Market Size by Application (2018-2023) & (US$ Million)
    Table 47. APAC Peptide CDMO Market Size by Application (2024-2029) & (US$ Million)
    Table 48. APAC Peptide CDMO Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 49. APAC Peptide CDMO Market Size by Region (2018-2023) & (US$ Million)
    Table 50. APAC Peptide CDMO Market Size by Region (2024-2029) & (US$ Million)
    Table 51. Bachem Company Details
    Table 52. Bachem Business Overview
    Table 53. Bachem Peptide CDMO Product
    Table 54. Bachem Revenue in Peptide CDMO Business (2018-2023) & (US$ Million)
    Table 55. Bachem Recent Development
    Table 56. PolyPeptide Company Details
    Table 57. PolyPeptide Business Overview
    Table 58. PolyPeptide Peptide CDMO Product
    Table 59. PolyPeptide Revenue in Peptide CDMO Business (2018-2023) & (US$ Million)
    Table 60. PolyPeptide Recent Development
    Table 61. CordenPharma Company Details
    Table 62. CordenPharma Business Overview
    Table 63. CordenPharma Peptide CDMO Product
    Table 64. CordenPharma Revenue in Peptide CDMO Business (2018-2023) & (US$ Million)
    Table 65. CordenPharma Recent Development
    Table 66. AmbioPharm Company Details
    Table 67. AmbioPharm Business Overview
    Table 68. AmbioPharm Peptide CDMO Product
    Table 69. AmbioPharm Revenue in Peptide CDMO Business (2018-2023) & (US$ Million)
    Table 70. AmbioPharm Recent Development
    Table 71. USV Peptides Company Details
    Table 72. USV Peptides Business Overview
    Table 73. USV Peptides Peptide CDMO Product
    Table 74. USV Peptides Revenue in Peptide CDMO Business (2018-2023) & (US$ Million)
    Table 75. USV Peptides Recent Development
    Table 76. Thermofischer Company Details
    Table 77. Thermofischer Business Overview
    Table 78. Thermofischer Peptide CDMO Product
    Table 79. Thermofischer Revenue in Peptide CDMO Business (2018-2023) & (US$ Million)
    Table 80. Thermofischer Recent Development
    Table 81. Bio Basic Company Details
    Table 82. Bio Basic Business Overview
    Table 83. Bio Basic Peptide CDMO Product
    Table 84. Bio Basic Revenue in Peptide CDMO Business (2018-2023) & (US$ Million)
    Table 85. Bio Basic Recent Development
    Table 86. JPT Company Details
    Table 87. JPT Business Overview
    Table 88. JPT Peptide CDMO Product
    Table 89. JPT Revenue in Peptide CDMO Business (2018-2023) & (US$ Million)
    Table 90. JPT Recent Development
    Table 91. Genscript Company Details
    Table 92. Genscript Business Overview
    Table 93. Genscript Peptide CDMO Product
    Table 94. Genscript Revenue in Peptide CDMO Business (2018-2023) & (US$ Million)
    Table 95. Genscript Recent Development
    Table 96. Xinbang Pharma Company Details
    Table 97. Xinbang Pharma Business Overview
    Table 98. Xinbang Pharma Peptide CDMO Product
    Table 99. Xinbang Pharma Revenue in Peptide CDMO Business (2018-2023) & (US$ Million)
    Table 100. Xinbang Pharma Recent Development
    Table 101. ScinoPharm Company Details
    Table 102. ScinoPharm Business Overview
    Table 103. ScinoPharm Peptide CDMO Product
    Table 104. ScinoPharm Revenue in Peptide CDMO Business (2018-2023) & (US$ Million)
    Table 105. ScinoPharm Recent Development
    Table 106. SN Biopharm Company Details
    Table 107. SN Biopharm Business Overview
    Table 108. SN Biopharm Peptide CDMO Product
    Table 109. SN Biopharm Revenue in Peptide CDMO Business (2018-2023) & (US$ Million)
    Table 110. SN Biopharm Recent Development
    Table 111. CBL Company Details
    Table 112. CBL Business Overview
    Table 113. CBL Peptide CDMO Product
    Table 114. CBL Revenue in Peptide CDMO Business (2018-2023) & (US$ Million)
    Table 115. CBL Recent Development
    Table 116. Piramal Pharma Company Details
    Table 117. Piramal Pharma Business Overview
    Table 118. Piramal Pharma Peptide CDMO Product
    Table 119. Piramal Pharma Revenue in Peptide CDMO Business (2018-2023) & (US$ Million)
    Table 120. Piramal Pharma Recent Development
    Table 121. CPC Scientific Company Details
    Table 122. CPC Scientific Business Overview
    Table 123. CPC Scientific Peptide CDMO Product
    Table 124. CPC Scientific Revenue in Peptide CDMO Business (2018-2023) & (US$ Million)
    Table 125. CPC Scientific Recent Development
    Table 126. Research Programs/Design for This Report
    Table 127. Key Data Information from Secondary Sources
    Table 128. Key Data Information from Primary Sources
List of Figures
    Figure 1. Peptide CDMO Product Picture
    Figure 2. Global Peptide CDMO Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 3. Global Peptide CDMO Market Size 2018-2029 (US$ Million)
    Figure 4. India Peptide CDMO Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 5. India Peptide CDMO Market Size 2018-2029 (US$ Million)
    Figure 6. India Peptide CDMO Market Share in Global 2018-2029
    Figure 7. Peptide CDMO Report Years Considered
    Figure 8. Product Picture of APIs and Intermediates
    Figure 9. Product Picture of FDF
    Figure 10. Global Peptide CDMO Market Share by Type in 2022 & 2029
    Figure 11. Global Peptide CDMO Market Size by Type (2018-2029) & (US$ Million)
    Figure 12. Global Peptide CDMO Market Share by Type (2018-2029)
    Figure 13. India Peptide CDMO Market Share by Type in 2022 & 2029
    Figure 14. India Peptide CDMO Market Size by Type (2018-2029) & (US$ Million)
    Figure 15. India Peptide CDMO Market Share by Type (2018-2029)
    Figure 16. Product Picture of Commercial
    Figure 17. Product Picture of Academic Research
    Figure 18. Product Picture of Other
    Figure 19. Global Peptide CDMO Market Share by Application in 2022 & 2029
    Figure 20. Global Peptide CDMO Market Size by Application (2018-2029) & (US$ Million)
    Figure 21. Global Peptide CDMO Market Share by Application (2018-2029)
    Figure 22. India Peptide CDMO Market Share by Application in 2022 & 2029
    Figure 23. India Peptide CDMO Market Size by Application (2018-2029) & (US$ Million)
    Figure 24. India Peptide CDMO Market Share by Application (2018-2029)
    Figure 25. The Top 5 and 10 Largest Companies of Peptide CDMO in the World: Market Share by Peptide CDMO Revenue in 2022
    Figure 26. Global Peptide CDMO Market Size Market Share by Region: 2018 VS 2022 VS 2029
    Figure 27. Global Peptide CDMO Market Share by Region (2018-2029)
    Figure 28. Americas Peptide CDMO Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 29. Americas Peptide CDMO Market Share by Type (2018-2029)
    Figure 30. Americas Peptide CDMO Market Share by Application (2018-2029)
    Figure 31. United States Peptide CDMO Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 32. Canada Peptide CDMO Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 33. Mexico Peptide CDMO Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 34. Brazil Peptide CDMO Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 35. EMEA Peptide CDMO Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 36. EMEA Peptide CDMO Market Share by Type (2018-2029)
    Figure 37. EMEA Peptide CDMO Market Share by Application (2018-2029)
    Figure 38. Europe Peptide CDMO Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 39. Middle East Peptide CDMO Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 40. Africa Peptide CDMO Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 41. China Peptide CDMO Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 42. China Peptide CDMO Market Share by Type (2018-2029)
    Figure 43. China Peptide CDMO Market Share by Application (2018-2029)
    Figure 44. APAC Peptide CDMO Market Size Growth Rate 2018-2029 (US$ Million)
    Figure 45. APAC Peptide CDMO Market Share by Type (2018-2029)
    Figure 46. APAC Peptide CDMO Market Share by Application (2018-2029)
    Figure 47. Japan Peptide CDMO Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 48. South Korea Peptide CDMO Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 49. China Taiwan Peptide CDMO Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 50. Southeast Asia Peptide CDMO Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 51. India Peptide CDMO Market Size Growth Rate (2018-2029) & (US$ Million)
    Figure 52. Bachem Revenue Growth Rate in Peptide CDMO Business (2018-2023)
    Figure 53. PolyPeptide Revenue Growth Rate in Peptide CDMO Business (2018-2023)
    Figure 54. CordenPharma Revenue Growth Rate in Peptide CDMO Business (2018-2023)
    Figure 55. AmbioPharm Revenue Growth Rate in Peptide CDMO Business (2018-2023)
    Figure 56. USV Peptides Revenue Growth Rate in Peptide CDMO Business (2018-2023)
    Figure 57. Thermofischer Revenue Growth Rate in Peptide CDMO Business (2018-2023)
    Figure 58. Bio Basic Revenue Growth Rate in Peptide CDMO Business (2018-2023)
    Figure 59. JPT Revenue Growth Rate in Peptide CDMO Business (2018-2023)
    Figure 60. Genscript Revenue Growth Rate in Peptide CDMO Business (2018-2023)
    Figure 61. Xinbang Pharma Revenue Growth Rate in Peptide CDMO Business (2018-2023)
    Figure 62. ScinoPharm Revenue Growth Rate in Peptide CDMO Business (2018-2023)
    Figure 63. SN Biopharm Revenue Growth Rate in Peptide CDMO Business (2018-2023)
    Figure 64. CBL Revenue Growth Rate in Peptide CDMO Business (2018-2023)
    Figure 65. Piramal Pharma Revenue Growth Rate in Peptide CDMO Business (2018-2023)
    Figure 66. CPC Scientific Revenue Growth Rate in Peptide CDMO Business (2018-2023)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4350

This license allows only one user to access the PDF.
Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6Q20319
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35Z19949
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26E19785
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions